M T Drayson
Overview
Explore the profile of M T Drayson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giles H, Drayson M, Kishore B, Pawlyn C, Kaiser M, Cook G, et al.
Blood Cancer J
. 2024 Mar;
14(1):50.
PMID: 38499538
Deeper responses are associated with improved survival in patients being treated for myeloma. However, the sensitivity of the current blood-based assays is limited. Historical studies suggested that normalisation of the...
2.
Emery A, Moore S, Crowe J, Murray J, Peacock O, Thompson D, et al.
BMC Cancer
. 2024 Feb;
24(1):174.
PMID: 38317104
Background: High levels of physical activity are associated with reduced risk of the blood cancer multiple myeloma (MM). MM is preceded by the asymptomatic stages of monoclonal gammopathy of undetermined...
3.
Shields A, Faustini S, Kristunas C, Cook A, Backhouse C, Dunbar L, et al.
J Dent Res
. 2021 Jun;
100(11):1220-1227.
PMID: 34077690
Dental care professionals (DCPs) are thought to be at enhanced risk of occupational exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, robust data to support this from large-scale...
4.
Cook A, Faustini S, Williams L, Cunningham A, Drayson M, Shields A, et al.
J Immunol Methods
. 2021 Mar;
494:113046.
PMID: 33775672
Background: Frequently SARS-CoV-2 results in mild or moderate disease with potentially lower concentrations of antibodies compared to those that are hospitalised. Here, we validated an ELISA using SARS-CoV-2 trimeric spike...
5.
6.
Shah V, Sherborne A, Walker B, Johnson D, Boyle E, Ellis S, et al.
Leukemia
. 2017 Jun;
32(1):102-110.
PMID: 28584253
Robust establishment of survival in multiple myeloma (MM) and its relationship to recurrent genetic aberrations is required as outcomes are variable despite apparent similar staging. We assayed copy number alterations...
7.
Jones J, Cairns D, Gregory W, Collett C, Pawlyn C, Sigsworth R, et al.
Blood Cancer J
. 2016 Dec;
6(12):e506.
PMID: 27935580
We have carried out the largest randomised trial to date of newly diagnosed myeloma patients, in which lenalidomide has been used as an induction and maintenance treatment option and here...
8.
Mandala W, Msefula C, Gondwe E, Drayson M, Molyneux M, MacLennan C
Parasite Immunol
. 2016 Mar;
38(5):317-25.
PMID: 27027867
Malaria in malaria-naïve adults is associated with an inflammatory response characterized by expression of specific activation markers on innate immune cells. Here, we investigate activation and adhesion marker expression, and...
9.
Lacourt T, Houtveen J, Veldhuijzen van Zanten J, Bosch J, Drayson M, van Doornen L
Brain Behav Immun
. 2014 Dec;
44:32-6.
PMID: 25451608
Introduction: Experimental animal studies provided evidence for a synergistic effect of immunological and psychological stressors on subsequent sickness behaviours. Up to now, little corroborating evidence for such synergy exists for...
10.
Khanim F, Merrick B, Giles H, Jankute M, Jackson J, Giles L, et al.
Blood Cancer J
. 2012 Jul;
1(10):e39.
PMID: 22829072
Despite recent therapeutic advancements, multiple myeloma (MM) remains incurable and new therapies are needed, especially for the treatment of elderly and relapsed/refractory patients. We have screened a panel of 100...